Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
MabSpace Biosciences Merged with HJB to Form Transcenta Holding, a Fully Integrated Leading Global Biotherapeutics Company
2019-01-02 12:37
InventisBio and Betta Pharma to Co-Develop Novel Drug for Non-Small Cell Lung Cancer
2018-12-29 03:33
Bridge Biotherapeutics Announces a Successful Activation of U.S. Clinical Trial Sites for BBT-401 Phase 2 Study
2018-12-28 07:00
China's NMPA Approves Innovent's Anti-PD-1 Antibody Tyvyt® (Sintilimab injection) for Hodgkin's Lymphoma
2018-12-27 16:45
I-Mab Receives U.S. FDA IND Approval for Proprietary Anti-GM-CSF Monoclonal Antibody TJM2
2018-12-24 11:45
CStone Pharmaceuticals announces initiation of CS1001 Phase I Study in U.S., patient enrollment under way
2018-12-21 17:50
Bridge Biotherapeutics Signs US$40M License Agreement with Daewoong Pharmaceutical for Co-development of UC Drug Candidate
2018-12-19 08:00
NeuClone Announces its Sixth Biosimilar Candidate Perjeta(R) (Pertuzumab) for use in Combination Therapy with Herceptin(R) (Trastuzumab)
2018-12-17 21:30
I-Mab and CSPC Pharma Announce Strategic Partnership for Long-acting GLP-1 Fc Program
2018-12-17 19:10
China Biologic Announces Dismissal of Lawsuit Filed in Cayman Islands by Former Chairman
2018-12-14 21:00
Innovent Announces Two Clinical Studies with the Anti-VEGF Monoclonal Antibody IBI305, a Biosimilar Candidate to Avastin (Bevacizumab), Met Primary Endpoints
2018-12-13 08:00
Mayne Pharma receives FDA approval of Tolsura™ (SUBA®-itraconazole capsules) for the treatment of certain fungal infections
2018-12-12 07:05
Cerecin Sponsors and Presents at Alzheimer's Disease Therapeutics: Alternatives to Amyloid Symposium
2018-12-11 16:05
World-first Approval For Multiple Myeloma Drug APLIDIN(R)
2018-12-11 15:10
Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Five Bispecific Antibody Programs for up to $450 Million
2018-12-11 09:47
CStone Pharmaceuticals Appoints Former MSD Global Oncology Early Development Executive Director Archie Tse, M.D., Ph.D., as the newly established SVP, Chief Translation Medicine Officer
2018-12-10 15:38
WuXi Biologics Wins SCRIP Award for "Best Company in an Emerging Market"
2018-12-06 18:12
CARsgen Presents Preliminary Results of CAR-BCMA T Cell Therapy at ASH 2018
2018-12-04 20:00
TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs
2018-11-29 15:40
Spring Pharmaceutical Group Inc. Starts Harvesting Seed Pods from Its Acer Truncatum Bunge Planting Bases
2018-11-27 20:00
1
134
135
136
137
138
165